<code id='7A94528FBA'></code><style id='7A94528FBA'></style>
    • <acronym id='7A94528FBA'></acronym>
      <center id='7A94528FBA'><center id='7A94528FBA'><tfoot id='7A94528FBA'></tfoot></center><abbr id='7A94528FBA'><dir id='7A94528FBA'><tfoot id='7A94528FBA'></tfoot><noframes id='7A94528FBA'>

    • <optgroup id='7A94528FBA'><strike id='7A94528FBA'><sup id='7A94528FBA'></sup></strike><code id='7A94528FBA'></code></optgroup>
        1. <b id='7A94528FBA'><label id='7A94528FBA'><select id='7A94528FBA'><dt id='7A94528FBA'><span id='7A94528FBA'></span></dt></select></label></b><u id='7A94528FBA'></u>
          <i id='7A94528FBA'><strike id='7A94528FBA'><tt id='7A94528FBA'><pre id='7A94528FBA'></pre></tt></strike></i>

          knowledge

          knowledge

          author:knowledge    Page View:91
          Photo of a doctor holding a cellphone. -- first opinion coverage from STAT
          Adobe

          Thinking about messaging your physician about a weird rash? You may want to hold off on it. Some hospital systems have started charging patients for digital messages to their doctors via the electronic medical record, either a flat rate (like a copay) or on sliding scale depending on the time or complexity of the physician’s response. Sometimes it’s billed through an insurer, sometimes as a direct cost to the patient. Costs have ranged between less than $10 and $100 for a message.

          Now that at least 22 hospital systems have implemented the practice, a great debate has broken out in the medical profession: Is charging patients to send a note to a doctor just common sense or an unjust expense?

          advertisement

          In asking family, friends, and colleagues about this, my grandmother’s response was the most enlightening: “I’m surprised doctors ever stopped charging for phone calls!”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Ventyx halts psoriasis drug development after lackluster trial results
          Ventyx halts psoriasis drug development after lackluster trial results

          AdobeSANDIEGO—VentyxBiosciencesreportedonMondaythatitwasendingdevelopmentofanexperimentaldrugfortrea

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          FDA's Pazdur wants cancer trials to range beyond China alone

          RichardPazdur,right,alsospokeabouttheFDA'suseofacceleratedapproval.MeganBearderPhotographyCHICAGO— T